Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant gender » significant concern (Expand Search), significant burden (Expand Search)
significant genes » significant benefits (Expand Search), significant changes (Expand Search), significant gap (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant gender » significant concern (Expand Search), significant burden (Expand Search)
significant genes » significant benefits (Expand Search), significant changes (Expand Search), significant gap (Expand Search)
-
1301
-
1302
<i>Shroom3</i> myocardial specific loss does not alter postnatal cardiac morphology.
Published 2025Subjects: -
1303
Risk of acquiring SARS-CoV-2 infection in the household (children vs. adults).
Published 2025Subjects: -
1304
-
1305
-
1306
-
1307
Most common symptoms and frequency of appearance among IgG-positive patients.
Published 2025Subjects: -
1308
-
1309
-
1310
Characteristics of patients with <i>ACE2ACE2</i> and <i>TMPRSS2</i> expression.
Published 2025Subjects: -
1311
Myocardial <i>Shroom3</i> loss during development does not show abnormal semilunar valves.
Published 2025Subjects: -
1312
-
1313
-
1314
-
1315
Myocardial <i>Shroom3</i> loss during development does not show ventricular septal defects.
Published 2025Subjects: -
1316
-
1317
-
1318
Myocardial <i>Shroom3</i> loss during development does not alter ventricular wall thickness.
Published 2025Subjects: -
1319
Embryonic <i>Shroom3</i><sup><i>Gt</i>/<i>Gt</i></sup> hearts show ventricular septal defects.
Published 2025Subjects: -
1320
<i>Shroom3</i> is expressed throughout the mouse myocardium during cardiogenesis.
Published 2025Subjects: